Sibylle Loibl, MD, PhD
Prof., MD ASCO, ESGO, ESMO, DKG, DGGG, AGO, DGS, BIG, BCIRG, St. Gallen Faculty Member, SABCS Faculty member
1
0
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Kenneth Offit, MD, MPH
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Steven Allen
Royal Marsden NHS Foundation Trust
Shared therapeutic areas:
Hyung Seok Park, MD, PhD
Severance Hospital
Shared therapeutic areas:
Susan Domchek, MD
University of Pennsylvania
Shared therapeutic areas:
Lei Li, M.D.
Peking Union Medical College Hospital
Shared therapeutic areas:
Melissa K Frey, MD, MS
Weill Medical College of Cornell University
Shared therapeutic areas:
Antonio Toesca, MD
European Institute of Oncology
Shared therapeutic areas:
Rana R. McKay, MD
University of California, San Diego
Shared therapeutic areas:
Derek Yang, MD
Acerand Therapeutics
Shared therapeutic areas:
Lillian Siu, MD
Princess Margaret Cancer Centre
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast Cancer
All 1 trials loaded